Fibromyalgia: Prevalence, Diagnosis, Management

Please Log In or Register to continue.

Release Date: June 04, 2010
Expiration Date: June 04, 2011

Expected time to complete this activity as designed: 30 minutes

Program Overview

Dr. Ricardo Cruciani discusses the prevalence, diagnosis and management of fibromyalgia.

Target Audience

This activity is designed for physicians who have an interest in enhancing their clinical skills in chronic pain management.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Diagnose fibromyalgia syndrome (FMS) accurately using key elements of current guideline criteria.
  • Identify practical approaches to the recognition, differentiation, assessment, and management of FMS in clinical practice.
  • Develop appropriate pharmacological and behavioral treatment interventions tailored to the individual needs of patients with FMS to better manage pain and improve quality of life.

General Information

This activity is eligible for credit through June 4, 2011. After this date, the activity will expire and no further credit will be awarded. There are no fees for participating in or receiving credit for this online educational activity.

Follow these steps to earn CME/CE credit:
1. Read the target audience, learning objectives, and author disclosures.
2. Complete the educational content online as designed or printed out.
3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score of 70% on the test and complete the Activity Evaluation to provide feedback for future programming.

Certificates may be printed immediately after successfully completing the online self-assessment post-activity and evaluation.

Faculty Biography

Ricardo A. Cruciani, MD, PhD
Director, Clinical Studies and Translational Research
Integrative Pain and Symptom Management Program
Department of Pain Medicine and Palliative Care
Beth Israel Medical Center
New York, New York

Dr. Ricardo Cruciani received his medical degree as well as a PhD in pharmacology from the University of Buenos Aires School of Medicine, Argentina. He completed residencies in psychiatry and neurology at Weill Medical College of Cornell University, as well as residencies in neurology at Memorial Sloan-Kettering Cancer Center, and Albert Einstein College of Medicine. Dr. Cruciani is currently director of Clinical Studies and Translational Research; the Integrative Pain and Symptom Management Program; and the Research Division, in the Department of Pain Medicine and Palliative Care at Beth Israel Medical Center, New York City.

His expertise in neurology, psychiatry, and pharmacology, as well as his training in basic science, gives Dr. Cruciani a multidimensional perspective on treating pain. He has lectured, published numerous medical articles, co-authored book chapters and abstracts, and conducted laboratory research on pain management. Dr. Cruciani’s primary focus is in chronic pain and the development of new treatment strategies.

Accreditation CREDIT
Accreditation Statement: MediCom Worldwide, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation Statement: MediCom Worldwide, Inc. designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.


In accordance with the Accreditation Council for Continuing Medical Education (ACCME), ACPE and California Board of Nursing, MediCom Worldwide, Inc. requires that all program planners, faculty, and providers who are in a position to control the content of a CME activity are required to disclose any relevant financial relationships they may have or have had within the last 12 months with the commercial supporter or the manufacturer(s) of any commercial device(s) discussed in this educational activity. Accordingly the following disclosures were made.

Faculty Disclosure

The presenting faculty reported the following:

Dr. Ricardo Cruciani has received honoraria related to speakers’ bureau activities from Endo Pharmaceuticals; King Pharmaceuticals, Inc.; Merck & Co., Inc.; and PriCara®, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. He has received consultant fees from PriCara, as well as grant support related to research activities from Ortho-McNeil®, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

Planner and Provider Financial Disclosures

The individuals listed below from MediCom Worldwide, Inc. reported the following for this activity: Joan Meyer, RN, MHA, executive director and Bronwyn Boyes, PharmD, director have nothing to disclose.

Adam J. Carinci, MD was the clinical reviewer for this activity and has nothing to disclose.

Conflict of Interest Resolution

To resolve identified conflicts of interest, the educational content was fully peer reviewed by members of the MediCom Content Review Committee. The resulting certified activity was found to provide educational content that is current, evidence-based, and fair balanced.

Off-Label Disclosures/Investigational Disclosures

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/ participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.

Dr. Cruciani indicated that his presentation would include the discussion of unlabeled or investigational/unapproved uses of opioids and adjuvant analgesics not yet approved by the FDA for use in the United States.

Hardware/Software Requirements

MediCom Worldwide, Inc. requires Internet Explorer® version 7.0 or higher, or Firefox 3.0 or higher, a computer running Windows® XP, Windows® Vista, or Mac OS X, 512MB of RAM or greater, 1.5 GHZ or faster processor, and a screen resolution of 1024x768 or higher. Certain educational activities may require additional software to view. These activities will be marked with the information and/or links to the required software. That software may be Adobe® Flash® Player, Adobe® Acrobat®, Windows Media® Player or Microsoft® Silverlight™.

If you have any questions or concerns regarding this activity, please contact MediCom Worldwide, Inc. at 1-800-408-4242 or email us at

Provided by MediCom Worldwide, Inc.

This activity is supported by an independent educational grant from Cephalon, Inc.

©2010 MediCom Worldwide, Inc., 101 Washington St., Morrisville, PA 19067.
No portion of this material may be copied or duplicated without the expressed permission of MediCom.

Please Log In or Register to continue.